National Pharmacare, Reference-Based Pricing, and Drug R&D: A Critique of the National Forum on Health's Recommendations for Pharmaceutical Policy
- 1 March 1999
- journal article
- Published by JSTOR in Canadian Public Policy
- Vol. 25 (1)
- https://doi.org/10.2307/3551399
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: